One Difference Between Amylyx’s ALS Drug And Aduhelm: A Biomarker Endpoint

 
• By Brenda Sandburg
ALS
Biomarker data could have helped show efficacy of Amylyx's ALS drug AMX0035 • Source: Alamy

More from US FDA Performance Tracker

More from Regulatory Trackers